Notice of AGM

RNS Number : 8953S

AstraZeneca PLC

14 March 2019

 

14 March 2019 12:00 GMT

Notice of Annual General Meeting

AstraZeneca PLC (the Company) announced today the publication of its Notice of Annual General Meeting 2019 and Shareholders' Circular (the Notice).

The Notice has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm. The Notice is also available on the Company's website at www.astrazeneca.com/agm.

The Company's Annual Report and Form 20-F Information 2018 was published on 5 March 2019.

The Notice is being despatched to shareholders today.

The meeting place for the Annual General Meeting (AGM) will be The Landmark London Hotel, 222 Marylebone Road, London NW1 6JQ and the AGM will commence at 2.30 pm (BST) on 26 April 2019.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit astrazeneca.com and follow us on Twitter @AstraZeneca.

Media Relations
Gonzalo Viña	UK/Global	[phone]
Rob Skelding	UK/Global	[phone]
Matt Kent	UK/Global	[phone]
Jennifer Hursit	UK/Global	[phone]
Christina Malmberg Hägerstrand	Sweden	[phone]
Michele Meixell	US	[phone]
Investor Relations
Thomas Kudsk Larsen		[phone]
Henry Wheeler	Oncology	[phone]
Christer Gruvris	BioPharma - Cardiovascular; Metabolism	[phone]
Nick Stone	BioPharma - Respiratory; Renal	[phone]
Josie Afolabi	Other	[phone]
Craig Marks	Finance; Fixed Income	[phone]
Jennifer Kretzmann	Retail Investors; Corporate Access	[phone]
US toll-free		[phone]

Adrian Kemp
Company Secretary

AstraZeneca PLC

 

END

 

 

NOAGGUUAWUPBGUC